NA Semax Amidate

NA Semax Amidate – Research-Grade Modified Heptapeptide

NA Semax Amidate is a synthetically modified heptapeptide derived from the ACTH (4–10) fragment sequence. The construct incorporates N-terminal acetylation and C-terminal amidation, resulting in a chemically defined peptide system structurally distinct from endogenous pituitary hormones and full-length proteins.

In laboratory research settings, NA Semax Amidate is utilized as a reference material for investigating peptide stability, receptor interaction models, and structure–function relationships associated with short neuroactive peptide analogs. The dual-terminal modification supports controlled evaluation of peptide persistence and interaction behavior under in vitro experimental conditions.

Unlike large biologics or multi-domain proteins, NA Semax Amidate represents a discrete and reproducibly synthesized peptide construct that enables mechanistic assays and comparative peptide studies in controlled research environments. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.